Dr. Vinayak Venkataraman, medical oncologist and director of Sarcoma Pathways at Dana-Farber Most cancers Institute in Boston, lately sat down with CURE...
The U.S. Meals and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational remedy being developed by Dewpoint Therapeutics...
On Sept. 5, 2025, the U.S. Meals and Drug Administration (FDA) accepted Inlexzo (gemcitabine intravesical system) for adults with Bacillus Calmette-Guérin (BCG)-unresponsive...
